Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blinded, Placebo-Controlled Extension to TRCA-301 Evaluating Long-term Safety and Durability of Effect of TRC101 in CKD Patients With Metabolic Acidosis
2017-002562-42Phase 3Completed
- Sponsor
- Tricida, Inc.
- Start
- Oct 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in metabolic acidosis comparing TRC101 with Placebo (2 arms). Started Oct 2017; status: completed.
02
Drugs
veverimer
03
Conditions
metabolic acidosis
Beyond the preview
Go deeper on 2017-002562-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002562-42.